10/17/2025Novo vs. KBP: Fraud or Due Diligence Slipup? (FierceBiotech)

10/16/2025Qilu Presents Promising Phase I Data for AR PROTAC Degrader QLH12016

10/16/2025Xuanzhu Bio Soars on Hong Kong Debut After Highly Oversubscribed IPO

10/16/2025Kailera Launches with $600M Series B to Advance GLP-1 Portfolio Acqui...

10/16/2025Belite Bio Secures Priority Review from China's NMPA for Tinlarebant

10/16/2025China NMPA Cancels 80 Drug Registration Certificates, Including Lorata...

10/16/2025NHC Holds High-Level Meetings with Abbott and Roche to Advance Healthc...

10/15/2025Pfizer CEO Calls for Greater U.S.–China Collaboration in Biopharma In...

10/15/2025Sino Biopharma's TQB2102 Receives Breakthru Therapeutic Designation in...

10/14/2025AskBio Reports Promising Safety Results from First Cohort of AB-1003 G...

10/14/2025Multitude Reports Updated Safety and Dose Findings for AMT-116 at ESMO...

10/14/2025Biokin and SystImmune Present Promising Early Data for EGFR×HER3 Bisp...

10/14/2025GSK's Shingrix Wins Chinese Approval for Expanded Use

10/13/2025CSPC's Novel siRNA Therapy Gains U.S. Green Light for Clinical Trials

10/13/2025USB's Zilbrysq Wins Chinese Approval

10/13/2025Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...

10/13/2025PegBio Signs Exclusive Licensing Term Sheet with UAE's PDC for PB-119

10/13/2025Micot Pharma Completes Over CNY 200M Series D Financing, Advances Towa...

10/13/2025Chengdu NRT Raises ~CNY 800M in Series D Financing to Advance Radiopha...

10/13/2025Expedition Therapeutics Secures USD 165M in Oversubscribed Series A

10/13/2025Walgreens Boots Alliance Fully Exits Nanjing Pharma

10/13/2025Hope Medicine Reports Positive Global Phase 2 Results for HMI-115

10/13/20254B Technologies' Novel NGF Receptor Inhibitor 4B03-04 Receives FDA IND...

10/13/2025Zenas Secures Global Rights to InnoCare's Orelabrutinib and Next-Gen I...

10/13/2025Eccogene Files for Hong Kong IPO

10/13/2025CF PharmaTech Soars 161% on Hong Kong IPO Debut

10/13/2025Kelun-Biotech Presents Promising Phase 1 Data for CLDN18.2 ADC SKB315

10/13/2025Huadao Bio Secures Over CNY 100M in Series D+2 Financing

10/13/2025AviadoBio and UgeneX Enter Exclusive Option-License Deal to Develop Op...

10/13/2025China Introduces New Regulations to Govern Clinical Research and Appli...

Page:32/825 Total number of articles:24749: [First][<<] [30] [31] [32] [33] [34] [>>] [End]